Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Pakistan State Oil: Rs. 206.89 billion (US$720 million) Karachi: Petroleum [2] 17: Standard Chartered Pakistan: Rs. 205.19 billion (US$710 million) Karachi: Banking [2] 18: Systems Limited: Rs. 181.10 billion (US$630 million) Lahore: Information technology [2] 19: Pakistan Oilfields Limited: Rs. 179.29 billion (US$620 million) Rawalpindi ...
The company started its operations in Pakistan as Glaxo Laboratories Pakistan Ltd and was listed on the Karachi Stock Exchange in 1951. [3]GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002.
For premium support please call: 800-290-4726 more ways to reach us
Pages in category "Pharmaceutical companies of Pakistan" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes. ...
Top five holdings: Alpine Immune Sciences, Revolution Medicines, Exact Sciences, BioMarin Pharmaceutical Average annual return since inception: 10.4% Expense ratio: 0.35%
According to the Economic complexity index, Pakistan is the 67th largest export economy in the world and the 106th most complex economy. [10] During the fiscal year 2015–16, Pakistan's exports stood at US$20.81 billion and imports at US$44.76 billion, resulting in a negative trade balance of US$23.96 billion. [11]